Halliburton (HAL) According to recent analysis by UBS, Halliburton Company (NYSE:HAL) beat adjusted earnings per share (EPS) estimates in Q2 2023, reporting.
/PRNewswire/ The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com s.